Kangmei Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Kangmei Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Kangmei Pharmaceutical Co Ltd Strategy Report
- Understand Kangmei Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Kangmei Pharmaceutical Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 29 Jan 2019 | GF Securities to Acquire 9.458% Stake in GF Fund Management from Kangmei Pharmaceutical | Acquisition |
GF Securities Co Ltd
|
GF Fund Management Co Ltd
|
| 22 Jun 2018 | Kangmei Pharma Raises USD154 Million in Public Offering of 7% Notes Due 2021 | Debt Offering | - |
Kangmei Pharmaceutical Co Ltd |
| 20 Apr 2018 | Kangmei Pharmaceutical Raises USD159.29 Million in Third Tranche of Public Offering of 5.5% Notes Due 2021 | Debt Offering | - |
Kangmei Pharmaceutical Co Ltd |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer